CPOY 76 COVID Experience Award of Excellence: The Vaccination of Denmark
The first Covid-19 vaccination took place the 27th of December 2020. When this project was made, half a year had gone since the first danish vaccination and we had 23 percent of the danish population fully vaccinated. But how much do we really know about the vaccines and will we manage to vaccinate almost 6 million people within a year? This project seeks to explore these questions to try and find out more about the vaccines lifespan form the invention in the laboratories to the vaccination of the population and everything in between.
Caption
Slide 4 of 12
February 16, 2021
Danish AdaptVac have since January 2020 worked on a new vaccine. The vaccine is a protein vaccine like we know it from the HPV vaccine. It consists of to parts, an empty virus particle and a SARS-CoV-2 antigen. AdaptVac is able to sort of glue the SARS antigen on the empty virus particle, which should give a very safe and effective vaccine. They have now moved past their pre clinical trials, which are experiments on animals. They have begun clinical trial phase one at Radboud University Medical College in Holland, which are done on a small amount of people. AdaptVac’s hope is to have the vaccine approved by late 2021.
Location
See more at cpoy.org